Join
Live feed
·
PRReleasevia Quantisnow
GE HealthCare Technologies Inc. logo

GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

ByQuantisnow·Wall Street's wire, on your screen.
GEHC· GE HealthCare Technologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GEHC (GE HealthCare Technologies Inc.) and more on Quantisnow.